Thromboprophylaxis for patients with cancer and central venous cathetersWithin the past 5 years, Dr. Schunemann received research grants, fees, and/or honoraria that were deposited into research accounts or received by a research group that he belongs to from AstraZeneca, Amgen, Chiesi Foundation, Lily, Pfizer, Roche, and UnitedBioSource for development or consulting regarding quality-of-life instruments for chronic respiratory diseases or as lecture fees related to the methodology of evidence-based practice guideline development and/or research methodology. Institutions or organizations with which that he is affiliated likely receive funding from for-profit sponsors that are supporting infrastructure and research that may serve his work. Based on a Cochrane Review first published in the Cochrane Library 2007, Issue 3. Cochrane Reviews are updated regularly as new evidence emerges and in response to comments and criticisms, and the Cochrane Library should be consulted for the most recent version of the review.